Frontiers in Cellular and Infection Microbiology

Papers
(The H4-Index of Frontiers in Cellular and Infection Microbiology is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development528
Antibiotics as Major Disruptors of Gut Microbiota350
ACE2, Much More Than Just a Receptor for SARS-COV-2261
Current Sampling Methods for Gut Microbiota: A Call for More Precise Devices236
Identification of the PANoptosome: A Molecular Platform Triggering Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)231
Antimicrobial Peptides: A New Hope in Biomedical and Pharmaceutical Fields208
The PANoptosome: A Deadly Protein Complex Driving Pyroptosis, Apoptosis, and Necroptosis (PANoptosis)201
Role and Mechanism of Gut Microbiota in Human Disease199
Antibiotic Resistance: One Health One World Outlook191
Fungi vs. Fungi in Biocontrol: An Overview of Fungal Antagonists Applied Against Fungal Plant Pathogens179
Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) Among Carbapenem-Resistant Enterobacteriaceae Isolated From Adult and Children Patients in China174
Modern Tools for Rapid Diagnostics of Antimicrobial Resistance160
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species143
SARS-COV-2 Variants: Differences and Potential of Immune Evasion141
Probiotic Gastrointestinal Transit and Colonization After Oral Administration: A Long Journey135
Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System117
The Female Vaginal Microbiome in Health and Bacterial Vaginosis114
The Role of the Gastrointestinal Mucus System in Intestinal Homeostasis: Implications for Neurological Disorders111
Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential110
Wuhan to World: The COVID-19 Pandemic106
T-Helper Cell Subset Response Is a Determining Factor in COVID-19 Progression106
Periodontal Disease: The Good, The Bad, and The Unknown105
Global Threat of Carbapenem-Resistant Gram-Negative Bacteria104
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine102
Urinary Microbiome: Yin and Yang of the Urinary Tract102
Association Between ABO Blood Group System and COVID-19 Susceptibility in Wuhan98
The Gut Microbiota in Inflammatory Bowel Disease97
Gut Microbiota Dysbiosis Associated With Altered Production of Short Chain Fatty Acids in Children With Neurodevelopmental Disorders97
Cathepsin L in COVID-19: From Pharmacological Evidences to Genetics96
Cytokine Profiles Associated With Acute COVID-19 and Long COVID-19 Syndrome96
Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of CO96
Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs95
Extracellular Vesicles in Fungi: Past, Present, and Future Perspectives91
Bacterial Vaginosis: Current Diagnostic Avenues and Future Opportunities90
The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking Therapies87
Promising Therapeutic Strategies Against Microbial Biofilm Challenges87
SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro87
Chitosan-Based Nanoparticles Against Viral Infections86
An Update on Molecular Diagnostics for COVID-1985
The Role of Porphyromonas gingivalis Outer Membrane Vesicles in Periodontal Disease and Related Systemic Diseases84
Desulfovibrio Bacteria Are Associated With Parkinson’s Disease82
Gut Microbiota Status in COVID-19: An Unrecognized Player?81
Immune Parameters and COVID-19 Infection – Associations With Clinical Severity and Disease Prognosis80
A Novel Scoring System for Prediction of Disease Severity in COVID-1980
Mechanism of the Gut Microbiota Colonization Resistance and Enteric Pathogen Infection79
Serum SARS-COV-2 Nucleocapsid Protein: A Sensitivity and Specificity Early Diagnostic Marker for SARS-COV-2 Infection78
Recent Advances in Molecular Diagnostics of Fungal Plant Pathogens: A Mini Review78
Gut Microbiota and Diarrhea: An Updated Review78
Impact of Gut Microbiota and Microbiota-Related Metabolites on Hyperlipidemia77
Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus76
Blood-Brain Barrier Disruption by Lipopolysaccharide and Sepsis-Associated Encephalopathy76
Quorum Sensing, Biofilm, and Intestinal Mucosal Barrier: Involvement the Role of Probiotic75
Proteus mirabilis Biofilm: Development and Therapeutic Strategies74
Escherichia coli as a Multifaceted Pathogenic and Versatile Bacterium74
Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy74
An Overview of Anti-Eukaryotic T6SS Effectors73
Gut Microbiome Reveals Specific Dysbiosis in Primary Osteoporosis72
Diversity of Hybrid- and Hetero-Pathogenic Escherichia coli and Their Potential Implication in More Severe Diseases72
Gardnerella vaginalis as a Cause of Bacterial Vaginosis: Appraisal of the Evidence From in vivo Models71
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict Efficacy71
Viral Infections, the Microbiome, and Probiotics70
Application of Metagenomic Next-Generation Sequencing in the Diagnosis of Pulmonary Infectious Pathogens From Bronchoalveolar Lavage Samples69
A Human 2D Primary Organoid-Derived Epithelial Monolayer Model to Study Host-Pathogen Interaction in the Small Intestine68
Structural Variations of Vaginal and Endometrial Microbiota: Hints on Female Infertility68
Virulence Factors of Pseudomonas Aeruginosa and Antivirulence Strategies to Combat Its Drug Resistance67
Bacterial Community Interactions During Chronic Respiratory Disease67
The Gut Microbiota (Microbiome) in Cardiovascular Disease and Its Therapeutic Regulation67
0.079245090484619